The replication and transcription activator (RTA), mainly encoded by open reading frame 50, is an immediate-early gene product that is conserved among all characterized gammaherpesviruses. Previous studies have demonstrated that RTA proteins of Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) can activate the promoter of many viral early lytic genes through direct or indirect mechanisms. Murine gammaherpesvirus 68 (MHV-68) is genetically related to KSHV and EBV, and the RTA homologue from MHV-68 also initiates the lytic cycle of gene expression. Although two RTA-dependent promoters had been identified in MHV-68, the mechanism of the interaction between RTA and the promoters was not characterized. In this study, we first identified an RTA-responsive promoter in the left origin of lytic replication region of MHV-68 through a reporter assay and mapped a 27-bp RTA-responsive element (RRE) through systematic deletions. Interestingly, sequence analysis identified a second RRE in this region. An electrophoretic mobility shift assay (EMSA) and a chromatin immunoprecipitation (ChIP) assay showed that RTA can bind directly to these two RREs in vitro or in vivo. Mutagenesis studies have further characterized the nucleotides important for mediating RTA binding by an EMSA. Moreover, we engineered RRE-deleted viruses and demonstrated in the context of the viral genome that one of the RREs mediates the RTA-dependent activation of an essential lytic gene, ORF18, during de novo infection. To our knowledge, this is the first time that RTA binding sites in MHV-68 have been identified. Since ORF18 regulates viral late gene expression, our study has also contributed to the delineation of the expression cascade of gammaherpesvirus lytic genes.
Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) (or human herpesvirus 8 ) are two human pathogens that are etiologically linked with a number of malignancies, such as lymphomas, nasopharyngeal carcinoma, and Kaposi's sarcoma (11, 12, 15, 19) . As such, they are also called tumor-associated herpesviruses. Like all herpesviruses, EBV and KSHV have two distinct phases in their life cycles, latency and lytic replication (4, 29) . However, studies of EBV and KSHV have been hampered by the lack of efficient de novo infection systems and suitable small-animal models. Murine gammaherpesvirus 68 (MHV-68 or ␥HV-68), a member of the gammaherpesvirus family phylogenetically related to EBV and KSHV, is a natural pathogen of wood mice (Apodemus sylvaticus) and occasionally bank voles (7, 25, 26, 45, 58) . Similar to EBV and KSHV, MHV-68 can establish lytic or latent infection. However, unlike EBV and KSHV, MHV-68 replicates robustly in permissive cell lines and generates progeny viruses to high titers. Moreover, when inoculated intranasally into a laboratory mouse, MHV-68 first undergoes lytic replication in respiratory epithelial cells and then spreads to lymphoid tissues, where latency is established mainly in B lymphocytes, macrophages, and dendritic cells (27) . The complete MHV-68 genome has been cloned into bacterial artificial chromosomes (BACs), facilitating the genetic manipulation of MHV-68 sequences (1) . This, together with the advancement of mouse genetics over the last 2 decades, makes MHV-68 an excellent experimental system to investigate basic aspects of gammaherpesvirus infection and virus-host interactions.
Both latency and lytic replication play important roles in gammaherpesviral tumorigenesis (31, 46, 51) . The switch from latency to lytic replication of KSHV is controlled by a virally encoded immediate-early protein, replication and transcription activator (RTA), that is conserved among all known gammaherpesviruses. RTA plays a critical role in both initiating the viral lytic cycle during de novo infection and reactivating KSHV from latency (42, 57) . RTA executes its functions mainly by acting as a transcriptional activator of many viral genes. It has a DNA binding domain at its N terminus and a transactivation domain at its C terminus. In KSHV, RTA activates the promoters of its own gene and many other viral genes, including polyadenylated nuclear RNA (PAN RNA), ORF6, ORF21, ORF57, ORF59, ORF74, K1, K5, K8, K9, K12, K14, K15, and viral interleukin-6 (vIL-6) (9, 13, 16, 17, 23, 24, 32, 33, 35, 40, 41, 49, 52, 59, 63, 66) . RTA controls these responsive promoters by at least two mechanisms. RTA binds directly to RTA-responsive elements (RREs) in viral promoters to activate the transcription of viral genes such as PAN, K1, K12, and vIL-6 (9, 10, 22, (52) (53) (54) , and in these cases, the RREs serve as RTA binding sites (RBSs). Alternatively, RTA is recruited to RREs in viral promoters such as those of ORF57 and K8 through interactions with other transcription factors (14, 33-36, 41, 42, 44, 60, 62) . In EBV, RTA in conjunction with another immediate-early protein, ZTA (also called ZEBRA or Z), initiates the viral lytic cycle through activating the expression of downstream lytic genes (30, 39) .
In MHV-68, RTA also serves as a molecular switch for the viral life cycle and is essential for initiating and driving the complete viral lytic cycle, leading to the release of newly produced viral particles (8, 48, 64) . It acts as a transcriptional activator of viral genes. Two MHV-68 RTA-dependent genes, ORF72 (v-cyclin) and ORF57, were previously reported. ORF72, playing an important role in virus reactivation, is transactivated by RTA. An RTA-responsive cis element (40 bp) was identified within the promoter of ORF72, but the mechanism of RTA controlling this element has not been further investigated (3) . RTA also activates the transcription of ORF57. Although two response elements, named RE-A (83-bp) and RE-B (57-bp), were identified within its promoter, it is not clear whether RTA interacts with these two elements through direct binding and whether RE-A and RE-B indeed mediate the RTA-dependent activation of ORF57 expression in the context of the viral genome (47) .
During lytic replication, herpesvirus genes are expressed in a cascade fashion. Viral DNA replication usually takes place after the expression of early genes and initiates from a region on the viral genome called the origin of lytic replication (oriLyt). Two oriLyt regions of KSHV have been identified (referred to as left and right oriLyt) (6, 38, 60) . In addition, it was shown previously that KSHV RTA binds to the left oriLyt and regulates oriLyt-associated transcription (60, 61) . As for MHV-68, we and another group have previously identified two oriLyt regions (2, 20, 28) . We have further mapped the minimal region of the left oriLyt to nucleotides (nt) 25695 to 26883 (28) . Analysis of the genomic locus around the left oriLyt region revealed a putative TATA box element located at nt 26708, close to the 3Ј end of the left oriLyt region. We thus hypothesized that, like KSHV RTA, MHV-68 RTA might recognize and bind to a promoter in the left oriLyt region and transactivate the expression of a downstream viral gene(s) (60, 61) .
In this study, we first used a reporter assay to investigate whether the left oriLyt region of MHV-68 contains a promoter that is responsive to RTA activation. Consistent with our hypothesis, RTA strongly activated the promoter in this region. A 27-bp RRE was mapped through systematic deletions. Interestingly, sequence analysis identified a second RRE in the left oriLyt region. An electrophoretic mobility shift assay (EMSA) and a chromatin immunoprecipitation (ChIP) assay showed that RTA can bind directly to these two RREs in vitro or in vivo. Mutagenesis studies have further characterized the nucleotides important for mediating RTA binding by EMSA. Moreover, we engineered RRE-deleted viruses and demonstrated in the context of the viral genome that one of the RREs mediates the RTA-dependent activation of an essential lytic gene, ORF18, during de novo infection.
MATERIALS AND METHODS
Cell culture and virus stocks. 293T, BHK-21, and NIH 3T3 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) medium supplemented with penicillin (100 units/ml), streptomycin (100 g/ml), and 10% fetal bovine serum and cultured at 37°C in the presence of 5% CO 2 . Virus stocks were prepared using BHK-21 cells, and viral titers were determined by a plaque assay on BHK-21 cells as described previously (65) .
Plasmid construction. Plasmid poriLyt was constructed by amplifying a 1.2-kb sequence of MHV-68 DNA (nt 25695 to 26883) using primers orilyt F (5Ј-TAA CGC GTG GTG AGC AGG TTC CGC A-3Ј) and orilyt R (5Ј-TAA GAT CTG ATC CGG GCC CCA GCT C-3Ј) and inserting the PCR product into the MluI and BglII sites of pGL3-Basic (Promega). The 5Ј deletion constructs of poriLyt were generated by PCR through a similar strategy.
A 120-bp MHV-68 DNA sequence (nt 26660 to 26780) was amplified by PCR using primers Rrf F (5Ј-TAA CGC GTC CTG GTG GAC ACC TTA AAG TAT TAC-3Ј) and Rrf R (5Ј-TAA GAT CTA ACC CAA AAC GAT CCG C-3Ј) and inserted into the MluI and BglII sites of pGL3-Basic to derive plasmid pRrf. The internal deletion mutants of pRrf were generated by using a PCR-based mutagenesis system. Briefly, a pair of primers (one of them was phosphorylated) in opposite directions was used in a PCR with plasmid pRrf as a template. After the PCR, the template DNA was removed by digestion with DpnI. The PCR products were then self-ligated and used to transform competent Escherichia coli cells. All deletion and site-directed mutations were confirmed by sequencing.
Plasmids pGL3RREA-P and pGL3RREAR-P were constructed by the insertion of a 27-bp sequence (5Ј-AAA AAG TCT CTT TTT GAT GTG TTT ACT-3Ј) into the MluI and BglII sites of pGL3-Promoter (Promega) in both directions. Plasmids pGL3RREB-P and pGL3RREBR-P were constructed by the insertion of a 27-bp sequence (5Ј-AAA GTA TTA CTT TTT GAT GTG TTT TAT-3Ј) into the MluI and BglII sites of pGL3-Promoter in both directions.
The RTA DNA binding domain (RDBD) sequence was amplified by primers RDBD-F (5Ј-GCG AAT TCG ATG GCC TCT GAC TCG GAT TCC CCT TCA GCC GAT AAG GAC TGG CAC GGA TCG AA-3Ј) and RDBD-R (5Ј-GCA AGC TTT TAA GAC AGT CCT GAA AAG ACCA-3Ј) and cloned into pET-30b(ϩ) (Novagen) via the EcoRI and HindIII sites to construct pET30b-RDBD for the expression of the His-tagged RTA binding domain in E. coli strain Rosetta(DE3).
The full ORF18 sequence (nt 29918 to 30773) was amplified by PCR using primers 18F (5Ј-GCG AAT TCG ATG TCC ACA TAT CCT CCC A-3Ј) and  18R (5Ј-GCA AGC TTT TAT TTT TGT GTG TTG GG-3Ј) and cloned into the EcoRI and BglII sites of the vector pCMV-HA (Clontech) to derive plasmid pORF18-HA.
Dual-luciferase reporter assay. The Dual-Luciferase reporter assay system (Promega) was used to test promoter activity. The reporter plasmids were individually transfected into 293T cells in a 24-well plate with either plasmid pCMV-FLAG-RTA or empty vector pCMV-FLAG. The pRL-CMV vector, which contains the coding sequence for Renilla luciferase under the control of a constitutively active cytomegalovirus (CMV) promoter, was included in each transfection mixture and served as an internal control for transfection efficiency. 293T cells were collected at 24 h posttransfection. Cells were washed with 1ϫ phosphate-buffered saline (PBS) and incubated with 100 l of 1ϫ passive lysis buffer (PLB) provided by the manufacturer. Lysates were centrifuged at top speed in a microcentrifuge for 5 min, and supernatants were assayed for reporter activities according to the manufacturer's protocol. RACE. Total RNA was extracted from BHK-21 cells 24 h after infection with MHV-68 (multiplicity of infection [MOI] of 1) using TRIzol reagent (Invitrogen). The ends of the ORF18 mRNA were identified by use of the FirstChoice RLM-RACE kit (Ambion). Briefly, for the 5Ј end, total RNA was treated with calf intestine alkaline phosphatase (CIP) to remove free 5Ј-phosphates. The cap structure found on intact 5Ј ends of mRNA was not affected by CIP. The RNA was then treated with tobacco acid pyrophosphatase (TAP) to remove the cap structure from full-length mRNA, leaving a 5Ј-monophosphate. A 45-base RNA adapter oligonucleotide was ligated into the RNA population using T4 RNA ligase. A random-primed reverse transcription reaction and subsequent nested PCR with a specific primer located at nt 26883 on the MHV-68 genome were then carried out. For the 3Ј end, first-strand cDNA was synthesized from total RNA by use of the supplied 3Ј rapid amplification of cDNA ends (RACE) adapter. The cDNA was then subjected to PCR using a 3Ј RACE primer, which is complementary to the anchored adapter, and another specific primer located at nt 28220 on the MHV-68 genome.
Construction of dRRE MHV-68 (BAC) by allelic exchange. dRREA BAC/ MHV-68, dRREB BAC/MHV-68, and dRREAB BAC/MHV-68 were generated by a two-step allelic exchange protocol in E. coli cells as described previously by Smith and Enquist (50) . The target construct was generated by overlap-extension PCR to delete the RRE. The flanking arms for the recombination of dRREA and dRREB encompassed nt 25693 to 26337 and nt 26320 to 26883 on the MHV-68 genome, respectively. Positive bacterial artificial chromosome (BAC) clones were identified by restriction enzyme digestion and further verified by Southern blotting. The recombinant BAC was transfected into BHK-21 cells.
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The supernatant from each transfection mixture was collected when cells showed a complete cytopathic effect (CPE), and the virus titer was determined by a plaque assay. EMSA. Oligonucleotides were labeled as described in the instructions for the Biotin 3Ј End DNA Labeling kit (Pierce). An electrophoretic mobility shift assay (EMSA) was performed as follows: end-labeled probes were individually incubated with either a nuclear protein extract containing ectopically expressed RTA or purified RDBD for 30 min in binding buffer [10 mM Tris-HCl (pH 7.5), 50 mM MgCl 2 , 1 g of poly(dI-dC), 1 mM dithiothreitol, and 50 mM ␤-mercaptoethanol] in a total volume of 15 l. For competition assays, a 100-fold amount of unlabeled oligonucleotides was added. For supershift assays, nuclear protein extracts containing the RTA protein were incubated with 0.8 l anti-Flag antibody for 10 min prior to the addition of the probe. After a further 30-min incubation on ice, the reaction mixtures were loaded onto a 5% native polyacrylamide gel in 0.5ϫ TGE buffer (2.5 mM glucose, 0.5 mM EDTA, and 1.25 mM Tris-HCl [pH 8.0]). After being run at 100 V at 4°C, DNAs were transferred onto a positively charged nylon membrane, and biotin-labeled DNAs were detected by chemiluminescence.
ChIP assay. 293T cells (2 ϫ 10 6 ) were transfected with pCMV-FLAG-RTA, and 36 h later, cells were infected with wild-type (wt) MHV-68 at an MOI of 1. After infection for 12 h, 1% formaldehyde was added to the medium for 10 min, and cells were collected. After washing with cold phosphate-buffered saline, the cells (2 ϫ 10 6 ) were suspended in 200 l of lysis buffer supplemented with 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and placed on ice for 10 min. The cells were then sonicated for 2 min, and the lysates were cleared by centrifugation for 10 min. The cell lysates were diluted 10-fold with dilution buffer. Chromatin solution (2 ml) was incubated with or without 2 l of anti-Flag antibody overnight at 4°C. Immune complexes were collected on protein G beads preadsorbed with sonicated salmon sperm DNA and then washed sequentially twice each in low-salt wash buffer, high-salt wash buffer, LiCl wash buffer, and Tris-EDTA (TE) buffer. Immune complexes were eluted from the beads by incubation in 500 l elution buffer. The solution was then added with 20 l of 5 M NaCl and heated at 65°C for 4 h to reverse DNA-protein cross-linking. After the addition of 10 l of 0.5 M EDTA, 20 l of 1 M Tris-HCl (pH 6.5), and 2 l of 10 mg/ml proteinase K, the solution was incubated for 1 h at 45°C. DNA was extracted with phenolchloroform-isoamyl alcohol and precipitated with ethanol. PCR analysis of immunoprecipitated DNA was carried out by using the following primers: RREACHIPF (5Ј-ACA GGT GGC ACT ATT GAT T-3Ј), RREACHIPR (5Ј-ACA GGT GGC ACT ATT GAT T-3Ј), RREBCHIPF (5Ј-AGA CCC TCT ACC TGG AAA-3Ј), RREBCHIPR (5Ј-AGA CAA GCT CGT GAA AGC-3Ј), ORF65CHIPF (5Ј-GTC AGG GCC CAG TCC GTA-3Ј), and ORF65CHIPR (5Ј-TGG CCC TCT ACC TTC TGT TGA-3Ј).
Southern blotting. Total cellular DNA was extracted, and 5 g of each DNA sample was digested overnight with NotI. For Southern blotting, the digested samples and molecular size markers were run on a 0.8% agarose gel in 1ϫ Tris-acetate-EDTA (TAE) buffer. The gel was treated with 0.25 M HCl, followed by alkaline denaturation and neutralization. DNA was transferred onto a Hybond-N ϩ membrane (Amersham Pharmacia) via capillary transfer in 10ϫ SSC buffer (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and immobilized by UV cross-linking. Southern blotting was carried out with DIG High Prime DNA Labeling and Detection Starter Kit II (Roche) with a probe against the terminal repeat region on the MHV-68 genome.
Northern blotting. Total RNA was isolated from cells with TRIzol reagent. Five micrograms of each RNA sample was loaded onto a 1% agarose-2% formaldehyde gel and separated by electrophoresis in 20 mM morpholinepropanesulfonic acid (MOPS) buffer (pH 7.0). An RNA ladder (0.5 to 6 kb; Takara) was included in each gel. The RNAs were transferred onto a nylon membrane and hybridized with a single-stranded biotin-labeled DNA probe.
The labeling reactions for single-stranded DNA (ssDNA) probes were performed in 20 l of reaction solution (2 l Taq polymerase buffer; 0.5 mM [each] dATP, dGTP, and dCTP; 0.25 mM dTTP; 0.25 mM biotin-dUTP; 400 ng of template DNA; 5 pmol primer; and 0.5 units of Taq polymerase). PCR was initiated with a denaturing step of 4 min at 94°C, followed by 50 cycles of sequential steps of 1 min at 94°C, 30 s at 53°C, and 1 min at 72°C. Finally, the reaction was extended for 5 min at 72°C.
RESULTS
Identification of an RTA-responsive element in the left oriLyt region of the MHV-68 genome. To investigate whether the left oriLyt region of MHV-68 contains an RTA-responsive promoter, we made a reporter construct in which the left oriLyt DNA sequence was cloned into the pGL3-Basic vector upstream of the luciferase coding sequence (Fig. 1A) and tested for its responsiveness to RTA activation. The reporter construct was cotransfected into 293T cells with either pCMV-FLAG-RTA or pCMV-FLAG, and promoter activities were examined. A luciferase reporter construct driven by the promoter of MHV-68 ORF57 served as a positive control. The result showed that in the presence of RTA, the oriLyt region was activated approximately 5,000-fold, whereas the empty vector pGL3-Basic was activated 5-fold, indicating that the MHV-68 oriLyt region did contain an RTA-responsive promoter (Fig. 1B) .
To map the RTA-responsive fragment within the MHV-68 oriLyt region, a panel of 5Ј deletions of the oriLyt DNA sequence was cloned into pGL3-Basic (Fig. 1A) and tested (Fig.  1B) . The deletion of the sequence between nt 26070 and 26187 (5Ј end of fragment D3 to 5Ј end of fragment D4) or nt 26553 and 26660 (5Ј end of fragment D7 to 5Ј end of fragment D8) resulted in less than a 3-fold reduction in RTA-dependent activation, whereas the sequence between nt 26660 and 26883 retained approximately a 1,700-fold activation by RTA. These results indicated that the sequence between nt 26660 and 26883 is critical for RTA transactivation.
We next sought to identify a fragment within this region that mediates RTA activation. A series of 20-bp internal deletions of the region between nt 26660 and 26780 (named Rrf) was made ( Fig. 2A) . Results from the reporter assays showed that these constructs all displayed low basal activities (Fig. 2B) . Two of the deletion constructs, d2Rrf and d3Rrf, essentially lost transactivation by RTA, whereas d1Rrf exhibited approximately a 3-fold reduction in RTA responsiveness compared to Rrf. On the other hand, d4Rrf and d5Rrf showed a notable increase in RTA transactivation due to the very low basal-level activity as a result of these internal deletions (Fig. 2C) . Furthermore, we transfected these Rrf reporter constructs into 293T cells, followed by de novo infection by MHV-68. The results shown in Fig. 2D and E were similar to those in Fig. 2B and C, confirming that these reporter plasmids behaved similarly during viral infection.
An inspection of the sequence spanning d2 and d3 (nt 26680 to 26720) revealed a canonical TATA box (TATAAA between nt 26707 and 26712) in the d3 region, suggesting that the left oriLyt region of MHV-68 indeed constitutes a promoter that is RTA dependent and that the region between nt 26660 and 26706 contains an RTA-responsive element (RRE).
RTA binds directly to the RTA-responsive element by an EMSA. RTA of gammaherpesviruses activates gene transcription through two distinct mechanisms: direct and indirect mechanisms (21, 55) . To determine whether MHV-68 RTA could bind directly to our mapped RRE, we performed an electrophoretic mobility shift assay (EMSA). Nuclear extracts containing the ectopically expressed Flag-tagged RTA protein were used in DNA binding reactions. Biotin-end-labeled probe a spans the entire region from nt 26660 to 26706 (Fig. 3A) . The addition of nuclear extracts to probe a resulted in the formation of a shifted complex (Fig. 3B, lane 2) . The mobility of this complex was further retarded by the addition of a monoclonal anti-Flag antibody (Fig. 3B, lane 3) , confirming that RTA is present in the shifted complex. The result clearly showed that RTA could bind directly to the sequence corresponding to nt 26660 to 26706 in the oriLyt region.
To determine the minimal DNA sequence required for RTA binding, a series of deletion probes was generated (Fig. 3A) , and EMSA was performed (Fig. 3B ). 5Ј deletion probe b and 3Ј deletion probe d displayed RTA binding similar to that of probe a (Fig. 3B, lanes 5 and 11) . However, 5Ј deletion probe c showed significantly reduced RTA binding (Fig. 3B, lane 8) , and the loss of 5 bp from nt 26701 to 26696 (probe e) abolished RTA binding (Fig. 3B, lane 14) . Therefore, the minimal DNA sequence for RTA binding corresponds to probe f (Fig. 3B,  lane 17) , spanning a 27-bp region from nt 26675 to nt 26701 on the MHV-68 genome.
An inspection of the MHV-68 left oriLyt segment revealed another 27-bp sequence in the opposite orientation located between nt 25983 and 26009. The sequence alignment shown in Fig. 3C revealed that the two RREs have remarkable sequence homology (74%) and share 20 identical nucleotides (underlined). Among these 20 nucleotides, a continuous 15-bp core sequence (5Ј-CTT TTT GAT GTG TTT-3Ј) was completely conserved in both RREs. To verify whether this RRE could also be bound by RTA, an EMSA was performed. The results showed that both RREs could be bound by RTA (Fig.  3C) , demonstrating that these RREs also serve as RBSs. Based on their locations in the MHV-68 genome, we named the sequence between nt 25983 and nt 26009 RREA and the sequence between nt 26675 and nt 26701 RREB.
Mutagenesis study of the RRE sequence. To characterize the interaction between RTA and RRE, we carried out an extensive mutagenesis study. Two base pair substitutions (A1 to A13) and one base pair substitution (A14) were made sequentially across the 27-bp RREA sequence (Fig. 4A) . The mutated sequences were designed to ensure that no other known transcription factor binding sites would be introduced. We then examined the effect of mutations on RTA binding in vitro. Mutant probes, in parallel with the wild-type RREA probe, were tested by EMSA, and the relative binding efficiency of each mutant probe was analyzed. We first used nuclear extracts containing the RTA protein for the EMSA. Although a shift of complexes of RTA and probes was detected, attempts to quantitatively analyze the relative binding efficiencies were complicated by the presence of several nonspecifically shifted bands (data not shown). To solve the problem, the RTA DNA binding domain (RDBD) (amino acids 1 to 339) (64) was expressed in E. coli strain Rosetta(DE3) cells and purified by use of a Ni-nitrilotriacetic acid (NTA) agarose column. The expression of the RDBD was confirmed by Western blotting (data not shown). The constructs containing the oriLyt fragments shown in panel A were cotransfected into 293T cells with either pCMV-FLAG or pCMV-FLAG-RTA in the presence of a control vector, pRL-CMV, which constitutively expresses Renilla luciferase driven by the cytomegalovirus immediate-early enhancer/ promoter. Cells were collected after 24 h, and dual-luciferase assays were performed. Firefly luciferase activities from the oriLyt fragment were normalized to the corresponding Renilla luciferase activities. The fold activation by RTA was calculated by comparing the normalized firefly luciferase activity stimulated by RTA to that stimulated in the presence of pCMV-FLAG. ORF57p, the ORF57 promoter of MHV-68, was used as a positive control. The data were compiled from three independent experiments, and standard deviations are shown.
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We then performed an EMSA with the purified RDBD. The purified RDBD could bind to the RREA probe, clearly demonstrating that RTA could bind to RREA independently of cellular or other viral proteins. In addition, the binding of the RDBD to RREA was dose dependent (Fig. 4B) . The effect of mutations in the RREA sequence on the RDBD binding efficiency was examined, as shown in Fig. 4C . Mutations A1, A2, and A7 to A14 markedly reduced RDBD binding in vitro. Among these, mutations A1, A2, A8, and A10 to A14 retained approximately 30 to 60% of wild-type binding activities. Notably, A9 retained less than 25% of the wild-type binding activity. In contrast, mutations A3 to A6 had little effect on RTA binding efficiencies. The relative binding efficiencies of all these mutations were summarized (Fig. 4A, right) . These results indicated that nucleotides AAAA (nt 26009 to 26006) and TGATGTGTTTACT (nt 25995 to 25983) in RREA are important for RTA binding in vitro. Among these, the AT nucleotides (nt 25993 to 25992) are most critical for RTA binding. Remarkably, these nucleotides that are important for RTA binding are also the conserved sequences between RREA and RREB, and the most critical AT nucleotides are located in the middle of the 15-bp conserved sequences. To test whether the AT binucleotides also play an important role in RTA binding in RREB, we synthesized a mutant probe, B9, based on RREB, with the AT nucleotides (nt 26691 to 26692) mutated, and examined its RTA binding ability by EMSA using nuclear extracts containing the ectopically expressed Flag-tagged RTA protein. To test the specificity of RTA binding, a competition experiment using an unlabeled RREB probe and a supershift experiment using an anti-Flag antibody were also performed (Fig. 4D, right) . For comparison, RREA and A9 were tested in the same assay (Fig. 4D, left) . Our results demonstrated that the AT binucleotide mutation in RREB had an effect on RTA binding similar to that in RREA, indicating that the AT binucleotides in RREB also play an important role in mediating RTA binding.
The RRE mediates RTA activation of a heterologous promoter. To determine whether the RRE of MHV-68 identified in our study can work as an enhancer and confer MHV-68 RTA responsiveness to a heterologous promoter, we cloned RREA in both orientations into the pGL3-Promoter vector, which contains a simian virus 40 (SV40) promoter, to obtain pGL3RREA-P and pGL3RREAR-P. We also constructed pGL3RREB-P and pGL3RREBR-P in the same manner. The constructs were transfected into 293T cells with either plasmid pCMV-FLAG-RTA or vector pCMV-FLAG. Results from the luciferase assays showed that whereas the pGL3-Basic vector was not activated by RTA (0.9-fold), all four plasmids were activated significantly by RTA. pGL3RREA-P and pGL3RREAR-P each were activated 117-and 59-fold, respectively, and for pGL3RREB-P and pGL3RREBR-P, activation by RTA reached 94-fold and 79-fold, respectively (Fig. 5A) . Since the 293T cell line is a human transformed epithelial cell line, we also carried out the same assay with NIH 3T3 cells, a mouse embryonic fibroblast cell line, and obtained similar results (Fig. 5B ). These data indicated that both RREA and RREB could act as enhancers and confer MHV-68 RTA responsiveness to a heterologous promoter independently of orientation or cell type.
RTA binds to the RRE on the MHV-68 genome in vivo. Our data presented above clearly indicated that RTA could bind directly to our mapped RREs in vitro and that RTA could activate a promoter fragment containing either RRE in a reporter assay. To explore whether the RTA protein indeed binds to RREA or RREB on the MHV-68 genome in vivo, we employed a ChIP technique. Briefly, 293T cells were transfected with pCMV-FLAG-RTA and infected 36 h later with wt MHV-68. After 12 h, cells were collected, and a ChIP assay was performed by precipitating RTA-chromatin fragment complexes using an anti-Flag antibody. RTA-bound DNAs were quantified by PCR by using a pair of primers that were designed to amplify the MHV-68 sequence between nt 25957 and nt 26072 (containing RREA) and nt 26469 and nt 26731 (containing RREB). PCR using a pair of primers specific for a region of ORF65 (nt 94185 to 94119), which should not contain an RRE, was used as a negative control. As shown in Fig.  6 , both of the fragments containing RREA or RREB were detected by PCR. As expected, the ORF65 coding region was not bound by RTA. These data confirmed that RTA can bind to viral genome sequences containing RREA or RREB during MHV-68 infection.
Generation and characterization of RRE-deleted MHV-68 viruses. Although our data so far demonstrated that RTA could bind to RREA or RREB in vitro and in vivo and could transactivate a reporter driven by the promoter in a plasmid system, it remained to be determined whether RREA or RREB mediates the RTA activation of downstream viral gene expression during virus infection and, if so, which viral genes are activated by RTA. We thus took advantage of the MHV-68 genome cloned as a bacterial artificial chromosome and constructed recombinant viruses in which RREA and RREB on the MHV-68 genome were deleted individually or in combination and replaced by a SalI restriction site(s) through allelic exchange (named dRREA BAC/MHV-68, dRREB BAC/ MHV-68, and dRREAB BAC/MHV-68, respectively) (Fig.  7A) . Appropriate recombinations were verified by restriction digestion and Southern blotting (Fig. 7B) . The combined digestion of the wt BAC/MHV-68 plasmid with SalI and NsiI resulted in a 16-kb fragment (Fig. 7B, lane 1) . The deletion of RREA or RREB resulted in the generation of a 9-kb fragment or a 7.7-kb fragment, respectively (Fig. 7B, lanes 2 and 3) . The deletion of both RREA and RREB resulted in the generation of a 0.7-kb fragment (Fig. 7B, lane 4) . No other rearrangement was detected in the recombinant viruses compared to wt BAC/ MHV-68. To further confirm the result, Southern blotting was performed by use of a probe against the region between RREA and RREB. No additional or unexpected hybridizing band was detected in the SalI-and NsiI-digested recombinant viral genome (Fig. 7B , lanes 6 to 8) compared to wt BAC/ MHV-68 (Fig. 7B, lane 5) . From these results, we concluded that RREA or RREB was successfully deleted, either individually or in combination, from the wt BAC/MHV-68 genome. 5 . RTA activates heterologous promoters in an orientationindependent manner. Synthetic oligonucleotides containing nt 26009 to 25984 (RREA) or nt 26675 to 26701 (RREB) were cloned in both orientations into the pGL3-Promoter vector containing the SV40 promoter. The orientation of RREA and RREB in pGL3RREAR-P and pGL3RREBR-P is the opposite of that in pGL3RREA-P and pGL3RREB-P, respectively. These constructs, plus pRL-CMV, were individually cotransfected into 293T cells (A) or NIH 3T3 cells (B) with pCMV-FLAG or pCMV-FLAG-RTA. The pGL3-Promoter vector served as a negative control. At 24 h posttransfection, cells were harvested, and a reporter assay was performed. The values represent averages of data from three independent experiments, and standard deviations are shown.
Next, BHK-21 cells were transfected with each BAC plasmid to reconstitute the wt or recombinant MHV-68 virus (dRREA MHV-68, dRREB MHV-68, and dRREAB MHV-68). The lytic replication of these four MHV-68 viruses was analyzed in a multiple-step growth curve experiment following a low multiplicity of infection of BHK-21 cells (MOI ϭ 0.02). Total viruses (including intracellular viruses and those in the supernatant) were harvested at the indicated time points, and virus titers were determined. As shown in Fig. 7C , the levels of replication of all four viruses had reached peak values by 72 h, and the titers of wt, dRREA, dRREB, and dRREAB MHV-68 were 4.3 ϫ 10 5 PFU/ml, 1.85 ϫ 10 5 PFU/ml, 2.4 ϫ 10 4 PFU/ml, and 2.7 ϫ 10 4 PFU/ml, respectively. dRREA MHV-68 replicated similarly to the wt virus; the titers of dRREB and dRREAB MHV-68 were similar, and both were approximately 1 log lower than that of wt MHV-68, indicating that the rep- Because RREA and RREB reside in the oriLyt region on the MHV-68 genome, we next investigated whether the deletion of RRE had any effect on viral lytic DNA replication during de novo infection. We individually infected BHK-21 cells with wt, dRREA, dRREB, or dRREAB MHV-68 (MOI ϭ 3) and harvested cells at 24 h postinfection. Total cellular DNAs were extracted, digested with NotI, and analyzed by Southern blotting. The results demonstrated that the genome replication efficiencies were similar among these viruses (Fig. 7D) , indicating that the growth defect of the RREB and RREAB deletion viruses was not due to defectiveness in viral DNA replication. This result is also consistent with our previous data showing that the fragmentbearing RRE region is not essential for the oriLyt-mediated DNA replication of MHV-68 (28).
RTA transactivates the expression of a 4-kb transcript encoding ORF18 through RREB. Another possible explanation for the attenuation of the dRREB and dRREAB viruses is that some viral gene product(s), whose expression is activated by RTA via RREB, is important for viral lytic replication. To test this, we sought to identify the target gene(s) of RTA around the RRE locus and to examine the effect of RTA on its expression.
Sequence analysis of the RRE locus on the MHV-68 genome (58) revealed that RREA and RREB are located upstream of open reading frame (ORF) K3 (leftward) as well as M5, M6, and ORF18 (rightward) (Fig. 8A) . In order to investigate whether these genes were transactivated by RTA through binding to RREA or RREB during virus infection, we individually infected BHK-21 cells with the four viruses (wt, dRREA, dRREB, or dRREAB MHV-68) and performed Northern blot analyses on total RNAs prepared from infected , and total RNAs of infected cells were harvested at 4 h and 8 h postinfection, followed by Northern blotting using biotin-labeled ssDNA probe c. (D) 293T cells were infected with wt MHV-68, dRREA MHV-68, dRREB MHV-68, or dRREAB MHV-68 in the presence (ϩ) or absence (Ϫ) of complementing pCMVHA-ORF18. At 24 h postinfection, viral antigen expression and the expression of exogenous ORF18-hemagglutinin (HA) were analyzed by Western blotting using a rabbit polyclonal anti-MHV-68 antiserum and a mouse monoclonal anti-HA antibody, respectively. Cellular ␤-actin antigen was examined in parallel as a loading control. (E) pORF18-HA (or pCMV-HA as a vector control) was transfected into 293T cells, and 24 h later, cells were infected with either dRREB or wt virus at an MOI of 0.1. Cells were harvested at the indicated time points for plaque assays.
cells. Based on the orientations of these predicted ORFs, we designed six single-stranded DNA probes to hybridize at different locations in this locus (Fig. 8A) . Probe a detected a 1.3-kb RNA product, whose expression level was not significantly different for all four virus infections. Probes c, d, and e each detected a single 4-kb RNA transcript at similar expression levels during wt or dRREA infection. However, the expression level of this transcript was severely reduced during dRREB or dRREAB infection. In contrast, probes b and f did not detect any transcript (Fig. 8B) . Because the expression level of the 4-kb transcript was severely reduced during dRREB and dRREAB MHV-68 infection, we focused our analysis on this transcript.
M5, M6, and ORF18 are all rightward ORFs located downstream of RREA and RREB. Leftward probe b overlaps with the coding sequences of M5 and M6, but by Northern blotting, we did not detect any transcript with this probe even during wt virus infection, suggesting that these two putative ORFs may not be expressed (at least not to a level detectable by Northern blotting at the time point that we examined). ORF18 encodes a protein that is essential for MHV-68 late gene transcription (5); however, its transcription unit has not yet been mapped. In our study, probe e overlapped with the ORF18 coding sequence, and only one 4-kb RNA band was detected by Northern blotting. Similarly, only one, and possibly the same, 4-kb RNA was detected by probes c and d. On the other hand, probe b or f did not detect any RNA band ( Fig. 8A and B) . Collectively, these data indicated that this 4-kb RNA was transcribed from a region of the MHV-68 genome that is between probes b and f.
Next, we carried out RACE analyses to identify the accurate termini of this transcript. 5Ј RACE and 3Ј RACE were performed on RNA prepared from BHK-21 cells infected with wt MHV-68. Based on the sequencing results with multiple independent clones, the 5Ј end of the 4-kb transcript was defined at nt 26737 (a position between probes b and c), and the 3Ј end was defined at nt 30792 (a position between probes e and f) (Fig. 8A ). An inspection of the surrounding genomic sequence of MHV-68 revealed a typical mRNA pattern: the transcription initiation site of the 4-kb transcript that we mapped is located 25 bp downstream of a TATA box, TATAAA (underlined in Fig. 8A ; also in italics and marked by an asterisk in Fig.  2A) , and the termination site is located at nt 30792, 19 bp downstream of a polyadenylation [poly(A)] signal, AATAAA (Fig. 8A) . The only intact ORF located within the transcript is ORF18; therefore, it is very likely that this 4-kb transcript is the mRNA for ORF18.
To further examine this hypothesis, we first characterized the temporal class of this transcript. BHK-21 cells were infected with wt MHV-68 in the presence or absence of cycloheximide (CHX) or phosphonoacetic acid (PAA). Total RNAs were harvested at different time points after infection, and Northern blotting was performed with probe e. The 4-kb RNA band was detected at 4 h and 8 h postinfection in the presence of PAA, whereas no product was detected in the presence of CHX (Fig. 8C) . The result implied that the 4-kb transcript is expressed from an early gene, consistent with the known temporal class of ORF18 (43) .
The function of the ORF18 protein was studied previously. The expression of viral lytic proteins, especially an 18-kDa lytic antigen, from an ORF18-null MHV-68 virus was strongly reduced compared to that from wt MHV-68; however, the expression of the lytic antigens could be rescued by exogenously expressed ORF18 (5) . To investigate the functional consequence of the RRE (especially RREB) deletion, we examined the expression of viral lytic antigens in BHK-21 cells individually infected with the mutant or wt virus using the same polyclonal antibody against MHV-68 lytic antigens as that described in a previous report (5) . An 18-kDa MHV-68 lytic antigen, presumably a late protein activated by ORF18, was expressed at a similar level in dRREA MHV-68-infected cells compared to wt MHV-68-infected cells but at a reduced level in dRREB or dRREAB MHV-68-infected cells (Fig. 8D , top, lanes 6 to 9). This reduction was rescued (Fig. 8D , top, lanes 4 and 5) by exogenously expressed ORF18 (Fig. 8D, middle) . Therefore, in this aspect, dRREB and dRREAB displayed a phenotype similar to (although less dramatic than) that of the ORF18-null virus.
To determine whether the ectopic expression of ORF18 could rescue the growth of the dRREB virus, we carried out a multiple-step growth curve assay of the dRREB virus in the presence or absence of exogenous ORF18 in comparison to wt MHV-68. In brief, cells were transiently transfected with pORF18-HA (or pCMV-HA as a vector control), followed by infection with either the dRREB or wt virus. Cells were harvested at the indicated time points for a plaque assay to determine viral growth properties. As shown in Fig. 8E , the peak titer of dRREB was approximately 1 log lower than that of wt MHV-68 in the absence of ectopically expressed ORF18. However, in cells transfected with pORF18-HA, the dRREB virus grew with kinetics similar to those of wt MHV-68 and reached a peak titer comparable to that of the wt virus at 48 h postinfection. The titer of the dRREB virus was slightly lower than that of the wt virus at 72 h postinfection, most likely due to the declined ORF18 protein level at this time point in the transient-transfection experiment, as pHA-ORF18 was transfected 24 h prior to infection. Western blot analysis of the same sample confirmed the expression of ectopic ORF18 as well as viral lytic genes such as ORF33 (data not shown). Thus, ectopically expressed ORF18 successfully rescued the growth of the dRREB virus. Taken together, our data strongly indicated that the 4-kb transcript is the mRNA of ORF18 and that its synthesis is activated by RTA through binding to RREB.
DISCUSSION
RTA is the "molecular switch" of MHV-68 and activates the expression of many downstream viral lytic genes. Previous studies have identified two RTA-dependent genes in MHV-68, ORF57 and ORF72 (3, 47) . Although RREs were identified in their promoters, the mechanism of the interaction between RTA and the promoters was not characterized. In this study, we have identified two additional RREs for MHV-68, namely, RREA and RREB. We have further demonstrated that RTA binds directly to RREA and RREB in vitro and in vivo and characterized the nucleotides important for mediating binding by RTA. To our knowledge, this is the first time that RTA binding sites in MHV-68 have been identified. Moreover, we have verified the functional significance of RREs in the context of the viral genome and have shown that RREB is responsible VOL. 85, 2011 MHV-68 RTA BINDS TO RRE AND ACTIVATES ORF18 11347
for mediating the RTA activation of ORF18 transcription during viral infection. The effect of the deletion of RREB on viral pathogenesis in vivo needs further investigation. In addition to the ORF18 transcript, the other transcript detected in the Northern blots shown in Fig. 8B is a 1.3 -kb RNA. Based on our analysis of this MHV-68 genomic locus (Fig. 8A ) and data from a previous report (18) , this transcript should be the mRNA for K3. K3 is transcribed in latently infected germinal center B cells as well as in the viral lytic cycle (56) , and its promoter includes elements both dependent on and independent of RTA (18) . Since the region containing RREA and RREB overlaps with the K3 promoter, we also tried to analyze the effect of the RRE deletion on K3 transcription. Quantitative analysis of the Northern blot (Fig. 8Ba) revealed that the transcript level of K3 from the dRREA or dRREB virus was slightly reduced compared to that from the wt virus, and the deletion of both RREA and RREB seemed to have a slightly accumulative effect on the K3 transcript level (data not shown). To more accurately examine the K3 transcription level during viral infection, we performed real-time reverse transcription (RT)-PCR. The RNA level of ORF6, whose transcription should not be affected by the RREA or RREB deletion, was used as an internal control. The results showed that, consistent with the result from the Northern blot analysis, either the RREA or RREB deletion resulted in a reduced level of K3 transcription, and the deletion of both RREA and RREB had an accumulative effect on the K3 transcript level (data not shown). However, statistical analysis of the Northern blot or real-time RT-PCR data indicated that none of the reduction was significant. Therefore, further investigation with a more relevant cell type or a context not mimicked in vitro is required to reveal the role of RREA and/or RREB in regulating K3 expression.
A comparison of RREA and RREB identified in our study with the RREs in the ORF57 and ORF72 promoter regions did not reveal any significant homology. However, a search of the complete MHV-68 genome led to the discovery of three additional 27-bp homologous sequences, located at nt 101295 to 101269, nt 101829 to 101855, and nt 101906 to 101932 (named RREC, RRED, and RREE, respectively). Sequence analysis showed that these three putative RREs have remarkable sequence homology with RREA and RREB, and all share a conserved 15-bp core sequence (5Ј-CTT TTT GAT GTG TTT-3Ј) (Fig. 9) . Interestingly, these three RREs are all located in the right oriLyt region of MHV-68 that we previously identified (20) . The RTA protein could bind to each one of them by EMSA (data not shown). It remains to be determined whether RTA associates with these putative RREs in vivo and, if so, what viral genes are regulated by them.
Since the RDBD of MHV-68 has a relatively high level of homology with its KSHV counterpart and may therefore share some characteristics in terms of DNA binding, we attempted to compare the MHV-68 RREs identified in this study with known KSHV RTA binding sites, such as RREs from the PAN RNA, K12, and vIL-6 promoters. The highest level of homology was found between RREA (5Ј-AAA AAG TCT CTT TTT GAT GTG TTT ACT-3Ј) and the vIL-6 RRE (3). However, among the 11 identical nucleotides (underlined), the binucleotides most important for MHV-68 RTA binding identified by EMSA (Fig. 4 , indicated with an asterisk) were not included. Neither RREA nor RREB bears a high level of similarity to the loose common motif derived from a previously described in vitro selection-and-amplification procedure (67) or the RTA consensus binding motif TTCCAGGAT(N) 0-16 T TCCTGGGA identified previously by use of a ChIP-on-chip assay system (17) . However, sequences in RREA and RREB do agree with the A/T 3 N 7 A/T 3 pattern found previously for KSHV PAN and K12 RREs (37) . A previous study showed that these phased A/T trinucleotides with arbitrary 7-nucleotide spacer sequences could provide an optimal RTA response (37) . Thus, although some similarities exist, the RREs also display considerable diversity, suggesting that other cellular or viral factors may be involved in mediating RTA binding to its promoters. The identification and characterization of more RTA binding sites and interaction partners and resolution of the crystallographic structure of the MHV-68 RTA protein will offer more insights into the mechanism of RTA binding and its role in transcriptional activation. A previous study utilizing an MHV-68 ORF18-null virus showed that the ORF18 protein plays an essential role in viral late gene transcription during MHV-68 infection (5). Moreover, through gene expression profiling and analysis of viral DNA synthesis, that study has identified ORF18 as an essential trans-factor for the expression of late genes. However, it was not clear how the expression of ORF18 itself is regulated. In this study, through a series of Northern blot analyses using single-stranded probes around the RRE locus, we have identified a 4-kb RNA species as the only transcript whose expression was significantly affected by the mutation of RREB from the viral genome (Fig. 8B) . Further characterization of this transcript by 5Ј and 3Ј RACE revealed that the transcript initiates downstream of the methione initiation codon of M6 but encompasses the complete ORF18. Together with the presence of a TATA box sequence and a poly(A) site by sequence analysis and results from the expression kinetics and ORF18 functional complementation assays, these data strongly indicated that this 4-kb transcript is the mRNA for ORF18. Understandably, the phenotype of the RREB or RREAB virus (Fig. 8B) was not as dramatic as that of the ORF18-null virus (5) . The mutation of only RREB strongly decreased the transcription level of ORF18, and a functional ORF18 protein would still be produced although at a reduced level. In contrast, no functional ORF18 protein could be produced as a result of the genetic engineering of the ORF18-null virus. Because ORF18 is essential for regulating the expression of viral late genes that encode structural proteins necessary for virion morphogenesis and egress, the reduction of ORF18 expression levels by the RREB and RREAB viruses offers an explanation for the delay in viral replication kinetics by these two mutant viruses compared to wt MHV-68 (Fig. 7C) .
ORF18 was the first identified trans-factor encoded by a gammaherpesvirus that regulates viral late gene expression (5). Our current study has thus also contributed to the delineation of the expression cascade of gammaherpesviral lytic genes: RTA as an immediate-early gene activates the expression of ORF18, an early gene, and ORF18 in turn activates the expression of viral late genes such as ORF26 and ORF65 (5). Collectively, work by us and others has further demonstrated the essential role of RTA as the central governor of MHV-68 lytic gene expression.
